x

Search for a networks

* (*) mandatory field

A phase 2b efficacy and safety study of PTC124 in subjects with nonsense-mutation-mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy (coordination)

  • Type of network : Multinational clinical trials
  • Geographic coverage : Global
  • Funding body(ies) : -
  • Sponsor : Ptc therapeutics, inc.
  • Website
  • Coordinator of multinational clinical trial

  • PTC THERAPEUTICS, INC.
  • PTC Therapeutics Inc.
  • 100 Corporate Court
  • SOUTH PLAINFIELD NJ 07080-2449
  • UNITED STATES
  • More information
  • Phone  : 190 82 22 70 00
  • Fax  : 190 82 22 72 31
  • Website
  • Contact secretary  :
Last update: May 2017

Participants

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.